Vitroprobe Analytics performs biomolecular analysis at the atomic scale to help design the pharmaceutical drugs of tomorrow. The development of new effective pharmaceutical drugs to fight disease is a slow and expensive process. Successful drug design relies on a profound understanding of the interactions between drug candidates and their target molecules in the body. The company has developed a unique platform to analyze target molecular structure in3D with simultaneous identification of individual constituent atoms. With the novel patented technique drug targets can be examined one atom at a time, thereby enabling fine-tuning of new pharmaceutical substances. The technology is the result of an interdisciplinary research program at Chalmers University of Technology.
Company Details
- Employees
- 5
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- BAAM Events.
Vitroprobe Analytics Questions
Vitroprobe Analytics's LinkedIn profile is https://www.linkedin.com/company/vitroprobe-analytics
Vitroprobe Analytics has
5 employees.
View email and phone details for 5
employees at Vitroprobe Analytics.
Vitroprobe Analytics's industry is
Biotechnology Research
Vitroprobe Analytics's top competitors are
Aquafood Ab,
Diagonal Bio,
Trygg Rätt,
Aladdin Project,
Amferia Kills Bacteria,
Intended Future,
Navari,
Svensk Medicin Ab,
Baam Events,
Mat4green Tech Ab.
Vitroprobe Analytics's categories are Biotechnology Research
Vitroprobe Analytics's founding year is 2020
